Summary
The global Pulmonary Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Inhaled Corticosteroids (ICS)
Long-Acting Beta2-Agonists (LABA)
Antihistamine
Vasodilators
Short-Acting Beta2-Agonists (SABA)
Anticholinergics
Combination Drugs
MAbs
Enzymes
Antibiotics & Antileukotrienes
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
AstraZeneca plc
Bayer AG
Teva Pharmaceutical Industries Ltd
Actelion Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
GlaxoSmithKline plc
Sunovion Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Inhaled Corticosteroids (ICS)
1.2.1.2 Long-Acting Beta2-Agonists (LABA)
1.2.1.3 Antihistamine
1.2.1.4 Vasodilators
1.2.1.5 Short-Acting Beta2-Agonists (SABA)
1.2.1.6 Anticholinergics
1.2.1.7 Combination Drugs
1.2.1.8 MAbs
1.2.1.9 Enzymes
1.2.1.10 Antibiotics & Antileukotrienes
1.2.2 by Application
1.2.2.1 Asthma & COPD
1.2.2.2 Allergic Rhinitis
1.2.2.3 Pulmonary Arterial Hypertension
1.2.2.4 Cystic Fibrosis
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Inhaled Corticosteroids (ICS) Market, 2013-2018
4.1.2 Long-Acting Beta2-Agonists (LABA) Market, 2013-2018
4.1.3 Antihistamine Market, 2013-2018
4.1.4 Vasodilators Market, 2013-2018
4.1.5 Short-Acting Beta2-Agonists (SABA) Market, 2013-2018
4.1.6 Anticholinergics Market, 2013-2018
4.1.7 Combination Drugs Market, 2013-2018
4.1.8 MAbs Market, 2013-2018
4.1.9 Enzymes Market, 2013-2018
4.1.10 Antibiotics & Antileukotrienes Market, 2013-2018
4.2 Market Forecast
4.2.1 Inhaled Corticosteroids (ICS) Market Forecast, 2019-2024
4.2.2 Long-Acting Beta2-Agonists (LABA) Market Forecast, 2019-2024
4.2.3 Antihistamine Market Forecast, 2019-2024
4.2.4 Vasodilators Market Forecast, 2019-2024
4.2.5 Short-Acting Beta2-Agonists (SABA) Market Forecast, 2019-2024
4.2.6 Anticholinergics Market Forecast, 2019-2024
4.2.7 Combination Drugs Market Forecast, 2019-2024
4.2.8 MAbs Market Forecast, 2019-2024
4.2.9 Enzymes Market Forecast, 2019-2024
4.2.10 Antibiotics & Antileukotrienes Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Asthma & COPD Market, 2013-2018
5.1.2 Allergic Rhinitis Market, 2013-2018
5.1.3 Pulmonary Arterial Hypertension Market, 2013-2018
5.1.4 Cystic Fibrosis Market, 2013-2018
5.2 Market Forecast
5.2.1 Asthma & COPD Market Forecast, 2019-2024
5.2.2 Allergic Rhinitis Market Forecast, 2019-2024
5.2.3 Pulmonary Arterial Hypertension Market Forecast, 2019-2024
5.2.4 Cystic Fibrosis Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 AstraZeneca plc
8.2 Bayer AG
8.3 Teva Pharmaceutical Industries Ltd
8.4 Actelion Pharmaceuticals, Inc.
8.5 Boehringer Ingelheim GmbH
8.6 F. Hoffmann-La Roche Ltd.
8.7 Merck & Co., Inc.
8.8 Novartis AG
8.9 GlaxoSmithKline plc
8.10 Sunovion Pharmaceuticals
9 Conclusion
Table Product Specifications of Pulmonary Drugs
Table Products Segment of Pulmonary Drugs
Table Inhaled Corticosteroids (ICS) Overview
Table Long-Acting Beta2-Agonists (LABA) Overview
Table Antihistamine Overview
Table Vasodilators Overview
Table Short-Acting Beta2-Agonists (SABA) Overview
Table Anticholinergics Overview
Table Combination Drugs Overview
Table MAbs Overview
Table Enzymes Overview
Table Antibiotics & Antileukotrienes Overview
Table Global Pulmonary Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Pulmonary Drugs
Table Asthma & COPD Overview
Table Allergic Rhinitis Overview
Table Pulmonary Arterial Hypertension Overview
Table Cystic Fibrosis Overview
Table Global Pulmonary Drugs Market by Application, 2011-2022 (USD Million)
Table Global Pulmonary Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Pulmonary Drugs
Table Market Dynamics
Table Policy of Pulmonary Drugs
Table GDP of Major Countries
Table Inhaled Corticosteroids (ICS) CAGR by Revenue and Volume, 2012-2018
Table Long-Acting Beta2-Agonists (LABA) CAGR by Revenue and Volume, 2012-2018
Table Antihistamine CAGR by Revenue and Volume, 2012-2018
Table Vasodilators CAGR by Revenue and Volume, 2012-2018
Table Short-Acting Beta2-Agonists (SABA) CAGR by Revenue and Volume, 2012-2018
Table Anticholinergics CAGR by Revenue and Volume, 2012-2018
Table Combination Drugs CAGR by Revenue and Volume, 2012-2018
Table MAbs CAGR by Revenue and Volume, 2012-2018
Table Enzymes CAGR by Revenue and Volume, 2012-2018
Table Antibiotics & Antileukotrienes CAGR by Revenue and Volume, 2012-2018
Table Inhaled Corticosteroids (ICS) CAGR by Revenue and Volume, 2012-2024
Table Long-Acting Beta2-Agonists (LABA) CAGR by Revenue and Volume, 2012-2024
Table Antihistamine CAGR by Revenue and Volume, 2012-2024
Table Vasodilators CAGR by Revenue and Volume, 2012-2024
Table Short-Acting Beta2-Agonists (SABA) CAGR by Revenue and Volume, 2012-2024
Table Anticholinergics CAGR by Revenue and Volume, 2012-2024
Table Combination Drugs CAGR by Revenue and Volume, 2012-2024
Table MAbs CAGR by Revenue and Volume, 2012-2024
Table Enzymes CAGR by Revenue and Volume, 2012-2024
Table Antibiotics & Antileukotrienes CAGR by Revenue and Volume, 2012-2024
Table Asthma & COPD CAGR by Revenue and Volume, 2012-2018
Table Allergic Rhinitis CAGR by Revenue and Volume, 2012-2018
Table Pulmonary Arterial Hypertension CAGR by Revenue and Volume, 2012-2018
Table Cystic Fibrosis CAGR by Revenue and Volume, 2012-2018
Table Global Pulmonary Drugs Market by Vendors, 2012-2018 (USD Million)
Table Global Pulmonary Drugs Market by Vendors, 2012-2018 (in Volume)
Table Global Pulmonary Drugs Market Share by Vendors, 2012-2018 (USD Million)
Table Global Pulmonary Drugs Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table AstraZeneca plc Profile List
Table Microecological Modulator Operating Data of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Profile List
Table Microecological Modulator Operating Data of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Actelion Pharmaceuticals, Inc. Profile List
Table Microecological Modulator Operating Data of Actelion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. Profile List
Table Microecological Modulator Operating Data of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Profile List
Table Microecological Modulator Operating Data of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sunovion Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Sunovion Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Pulmonary Drugs Picture
Figure Industry Chain Structure of Pulmonary Drugs
Figure SWOT of Pulmonary Drugs
Figure Inhaled Corticosteroids (ICS) Market Size and Growth, 2012-2018 (USD Million)
Figure Inhaled Corticosteroids (ICS) Market Size and Growth, 2012-2018 (in Volume)
Figure Long-Acting Beta2-Agonists (LABA) Market Size and Growth, 2012-2018 (USD Million)
Figure Long-Acting Beta2-Agonists (LABA) Market Size and Growth, 2012-2018 (in Volume)
Figure Antihistamine Market Size and Growth, 2012-2018 (USD Million)
Figure Antihistamine Market Size and Growth, 2012-2018 (in Volume)
Figure Vasodilators Market Size and Growth, 2012-2018 (USD Million)
Figure Vasodilators Market Size and Growth, 2012-2018 (in Volume)
Figure Short-Acting Beta2-Agonists (SABA) Market Size and Growth, 2012-2018 (USD Million)
Figure Short-Acting Beta2-Agonists (SABA) Market Size and Growth, 2012-2018 (in Volume)
Figure Anticholinergics Market Size and Growth, 2012-2018 (USD Million)
Figure Anticholinergics Market Size and Growth, 2012-2018 (in Volume)
Figure Combination Drugs Market Size and Growth, 2012-2018 (USD Million)
Figure Combination Drugs Market Size and Growth, 2012-2018 (in Volume)
Figure MAbs Market Size and Growth, 2012-2018 (USD Million)
Figure MAbs Market Size and Growth, 2012-2018 (in Volume)
Figure Enzymes Market Size and Growth, 2012-2018 (USD Million)
Figure Enzymes Market Size and Growth, 2012-2018 (in Volume)
Figure Antibiotics & Antileukotrienes Market Size and Growth, 2012-2018 (USD Million)
Figure Antibiotics & Antileukotrienes Market Size and Growth, 2012-2018 (in Volume)
Figure Inhaled Corticosteroids (ICS) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Inhaled Corticosteroids (ICS) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Long-Acting Beta2-Agonists (LABA) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Long-Acting Beta2-Agonists (LABA) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Antihistamine Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Antihistamine Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Vasodilators Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Vasodilators Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Short-Acting Beta2-Agonists (SABA) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Short-Acting Beta2-Agonists (SABA) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Anticholinergics Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Anticholinergics Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Combination Drugs Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Combination Drugs Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure MAbs Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure MAbs Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Enzymes Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Enzymes Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Antibiotics & Antileukotrienes Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Antibiotics & Antileukotrienes Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Asthma & COPD Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Allergic Rhinitis Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Pulmonary Arterial Hypertension Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Cystic Fibrosis Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Pulmonary Drugs Market Concentration by Region
Figure Marketing Channels Overview
